Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Patent Publication Number 20230227548
US 20230227548 A1Patent NumberUS 11884722 B2
Application Number18157800
Filled DateJan 20, 2023
Priority DateJul 20, 2016
Publication DateJul 20, 2023
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsMark Mendonca
Suzanne Edavettal
Nathan Majewski
Leopoldo L. Luistro, III
Francois Gaudet
Ricardo Attar
Kodandaram Pillarisetti
Diana Chin
Leopoido Luistro
Yingzhe Li
Mark Tornetta
Alexey Teplyakov
Suzanne Edavettal
Nathan Majewski
Leopoldo L. Luistro, III
Francois Gaudet
Ricardo Attar
Kodandaram Pillarisetti
Diana Chin
Leopoido Luistro
Yingzhe Li
Mark Tornetta
Alexey Teplyakov
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.